Novartis Beats Patent Listing Suit Over Entresto

By Bryan Koenig · September 24, 2026, 8:13 PM EDT

A New York federal judge gave Novartis permanent relief from a proposed class action alleging it monopolistically delayed generic competition for its blockbuster heart failure drug Entresto, concluding that the drugmaker...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

The Iron Workers Local 580 Insurance Fund v. Novartis Pharmaceuticals Corporation

Case Number

1:25-cv-07230

Court

New York Southern

Nature of Suit

Other Statutory Actions

Date Filed

August 29, 2025